BALYASNY ASSET MANAGEMENT L.P. - KRYSTAL BIOTECH INC ownership

KRYSTAL BIOTECH INC's ticker is KRYS and the CUSIP is 501147102. A total of 162 filers reported holding KRYSTAL BIOTECH INC in Q1 2023. The put-call ratio across all filers is 1.80 and the average weighting 0.2%.

Quarter-by-quarter ownership
BALYASNY ASSET MANAGEMENT L.P. ownership history of KRYSTAL BIOTECH INC
ValueSharesWeighting
Q3 2023$3,786,472
-11.9%
32,642
-10.8%
0.01%
-11.1%
Q2 2023$4,295,666
+30.4%
36,590
-11.0%
0.01%
+12.5%
Q1 2023$3,293,268
+396.3%
41,135
+391.1%
0.01%
+300.0%
Q4 2022$663,5478,3760.00%
Other shareholders
KRYSTAL BIOTECH INC shareholders Q1 2023
NameSharesValueWeighting ↓
Redmile Group, LLC 2,003,367$232,390,57211.06%
Frazier Life Sciences Management, L.P. 988,460$114,661,3607.62%
S Squared Technology, LLC 108,215$12,552,9406.77%
Avoro Capital Advisors LLC 2,565,555$297,604,3804.64%
APIS CAPITAL ADVISORS, LLC 24,000$2,784,0003.61%
Nicholas Investment Partners, LP 355,611$41,250,8763.08%
Ghost Tree Capital, LLC 80,000$9,280,0003.05%
SILVERARC CAPITAL MANAGEMENT, LLC 71,531$8,297,5962.52%
Affinity Asset Advisors, LLC 57,500$6,670,0001.88%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 46,092$5,344,8281.80%
View complete list of KRYSTAL BIOTECH INC shareholders